BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9422409)

  • 1. Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation.
    Tanabe K; Tokumoto T; Ishikawa N; Koyama I; Takahashi K; Fuchinoue S; Kawai T; Koga S; Yagisawa T; Toma H; Ota K; Nakajima H
    Transplantation; 1997 Dec; 64(12):1721-5. PubMed ID: 9422409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus diagnosis in renal and bone marrow transplant recipients: the impact of molecular assays.
    Halwachs-Baumann G; Wilders-Truschnig M; Enzinger G; Eibl M; Linkesch W; Dornbusch HJ; Santner BI; Marth E; Kessler HH
    J Clin Virol; 2001 Jan; 20(1-2):49-57. PubMed ID: 11163583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time PCR assay compared with antigenemia assay for detecting cytomegalovirus infection in kidney transplant recipients.
    Kim DJ; Kim SJ; Park J; Choi GS; Lee S; Kwon CD; Ki C; Joh J
    Transplant Proc; 2007 Jun; 39(5):1458-60. PubMed ID: 17580161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of cytomegalovirus positivity in the peripheral blood samples of risky patients by shell-vial cell culture, antigenemia test and real-time polymerase chain reaction].
    Gökahmetoğlu S; Yağmur G; Mutlu Sarıgüzel F; Deniz E
    Mikrobiyol Bul; 2011 Apr; 45(2):288-95. PubMed ID: 21644072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cytomegalovirus antigenemia and shell vial culture in allogeneic marrow transplantation recipients receiving ganciclovir prophylaxis.
    Nicholson VA; Whimbey E; Champlin R; Abi-Said D; Przepiorka D; Tarrand J; Chan K; Bodey GP; Goodrich JM
    Bone Marrow Transplant; 1997 Jan; 19(1):37-41. PubMed ID: 9012929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation--a report of 130 consecutive patients.
    van den Berg AP; van der Bij W; van Son WJ; Anema J; van der Giessen M; Schirm J; Tegzess AM; The TH
    Transplantation; 1989 Dec; 48(6):991-5. PubMed ID: 2556817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of PCR serum in diagnosing and monitoring cytomegalovirus reactivation in bone marrow transplant recipients.
    Matsunaga T; Sakamaki S; Ishigaki S; Kohda K; Takeda M; Katoh J; Kuroda H; Hirayama Y; Kusakabe T; Akiyama T; Kuga T; Niitsu Y; Masaoka T; Sagawa T; Matsumoto Y
    Int J Hematol; 1999 Feb; 69(2):105-11. PubMed ID: 10071460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical usefulness of plasma quantitative polymerase chain reaction assay: diagnosis of cytomegalovirus infection in kidney transplant recipients.
    Rhee JY; Peck KR; Lee NY; Song JH
    Transplant Proc; 2011 Sep; 43(7):2624-9. PubMed ID: 21911135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for detection of cytomegalovirus in blood leukocytes from solid-organ transplant recipients.
    Storch GA; Buller RS; Bailey TC; Ettinger NA; Langlois T; Gaudreault-Keener M; Welby PL
    J Clin Microbiol; 1994 Apr; 32(4):997-1003. PubMed ID: 8027357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cytomegalovirus (CMV) antigenemia and CMV in bronchoalveolar lavage fluid for diagnosis of CMV pulmonary infection after bone marrow transplantation.
    Sakamaki H; Yuasa K; Goto H; Tanikawa S; Akiyama H; Onozawa Y; Okamoto R; Maeda Y; Sasaki T; Kaku H; Tsuzuki S; Takamoto S; Mochida Y; Minematsu T; Minamishima Y
    Bone Marrow Transplant; 1997 Jul; 20(2):143-7. PubMed ID: 9244418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients.
    Piiparinen H; Höckerstedt K; Grönhagen-Riska C; Lautenschlager I
    J Clin Virol; 2004 Jul; 30(3):258-66. PubMed ID: 15135746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.
    Yakushiji K; Gondo H; Kamezaki K; Shigematsu K; Hayashi S; Kuroiwa M; Taniguchi S; Ohno Y; Takase K; Numata A; Aoki K; Kato K; Nagafuji K; Shimoda K; Okamura T; Kinukawa N; Kasuga N; Sata M; Harada M
    Bone Marrow Transplant; 2002 Apr; 29(7):599-606. PubMed ID: 11979310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients.
    Caliendo AM; St George K; Kao SY; Allega J; Tan BH; LaFontaine R; Bui L; Rinaldo CR
    J Clin Microbiol; 2000 Jun; 38(6):2122-7. PubMed ID: 10834964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients.
    Piiparinen H; Helanterä I; Lappalainen M; Suni J; Koskinen P; Grönhagen-Riska C; Lautenschlager I
    J Med Virol; 2005 Jul; 76(3):367-72. PubMed ID: 15902704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shell-vial culture and pp65 antigenemia assay in the detection of cytomegalovirus in the first blood sample of renal transplant recipients.
    Reina J; Fernandez-Baca V; Saurina J; Blanco I; Munar M
    J Med Virol; 1998 Jul; 55(3):240-2. PubMed ID: 9624613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of serology, antigenemia assay and the polymerase chain reaction for monitoring active cytomegalovirus infections in hematopoietic stem cell transplantation patients.
    Bonon SH; Rossi CL; de Souza CA; Vigorito AC; Costa SC
    Rev Inst Med Trop Sao Paulo; 2006; 48(5):275-8. PubMed ID: 17086316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of PCR in the diagnosis and management of CMV in solid organ recipients: what is the predictive value for the development of disease and should PCR be used to guide antiviral therapy?
    Abecassis MM; Koffron AJ; Kaplan B; Buckingham M; Muldoon JP; Cribbins AJ; Kaufman DB; Fryer JP; Stuart J; Stuart FP
    Transplantation; 1997 Jan; 63(2):275-9. PubMed ID: 9020330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing serology, antigenemia assay and polymerase chain reaction for the diagnosis of cytomegalovirus infection in renal transplant patients.
    Bhatia J; Shah BV; Mehta AP; Deshmukh M; Sirsat RA; Rodrigues C
    J Assoc Physicians India; 2004 Apr; 52():297-300. PubMed ID: 15636331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cytomegalovirus antigenemia and culture assays in patients on and off antiviral therapy.
    St George K; Rinaldo CR
    J Med Virol; 1999 Sep; 59(1):91-7. PubMed ID: 10440814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.